academic article

• Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort..  International journal of methods in psychiatric research.  22:46-58. 2013
• 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery..  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.  21:287-293. 2011
• Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM)..  European psychiatry : the journal of the Association of European Psychiatrists.  25:338-344. 2010
• Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice..  International clinical psychopharmacology.  25:257-263. 2010
• Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania..  The Journal of clinical psychiatry.  71:255-261. 2010
• Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)..  Journal of affective disorders.  118:118-123. 2009
• Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study..  Pharmacopsychiatry.  42:145-152. 2009
• Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis..  The Journal of nervous and mental disease.  197:35-40. 2009
• Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study..  Journal of affective disorders.  106:63-72. 2008
• Functional impairment in patients with mania: baseline results of the EMBLEM study..  Bipolar disorders.  9:45-52. 2007